期刊文献+

白血病细胞源树突状细胞功能测定 被引量:1

Antigen presenting function of dendritic cells derived from leukemia cells
下载PDF
导出
摘要 目的:观察体外诱导的白血病细胞源树突状细胞(DC)的抗原递呈功能。方法:分离初诊8例急性髓细胞性白血病(AML)、9例慢性髓细胞性白血病(CML)患者和6例正常人的骨髓单个核细胞,用rhGM-CSF、rhIL-4和TNF-α诱导培养。分别于培养第1、6、14天用倒置显微镜进行形态学观察,流式细胞术检测免疫学表型,用混合淋巴细胞反应检测抗原递呈功能。结果:经诱导培养,AML,CML和正常组骨髓单个核细胞均出现DC典型形态的细胞,而且免疫标记差异无统计学意义(P>0.05)。混合淋巴细胞反应结果显示,AML-DC、CML-DC和正常DC诱导生成的细胞毒T淋巴细胞(CTL)能够杀灭白血病细胞,AML-DC、CML-DC之间刺激T细胞增殖的能力相似(P>0.05),但2者刺激T细胞增殖的能力均低于正常DC(P<0.05)。结论:急性和慢性白血病细胞均能诱导分化成DC,但其抗原递呈功能较弱。 Aim : To observe the function of antigen presenting of dendritic cells (DCs) from primary acute myeloid leukemia(AML) and chronic myiloid leukemia(CML) cells. Methods:Bone marrow mononuclear cells(MNCs) were isola- ted from 8 patients with AML,9 patients with CML and 6 healthy donors, and co-cuhured with rhGM-CSF, rhlL-4 and TNF-ct. The morphologic features were observed by inverted microscope at Day 1,6, 14; CD80,CD86, CD1 a, HLA-DR ex- pression were assayed by flowcytometry, the function of antigen presenting were tested by mixed lymphocyte reaction (MLR). Results: After cultured with cytokines, cells appearing the typical morphologic features and immunophentypes of DCs were founded in AML,CML and normal groups. The result of MLR showed that DCs of the three groups could stimulate the T cells to be CTL, which could kill the leukemia cells. The morphologic features, immunophentype expression and anti- gen presenting function of AML-DCs and CML-DCs did not differ from each other( P 〉 O. 05 ) , but the antigen presenting function of AML-DCs and CML-DCs were weaker than that of the normal DCs. Conclusion: Primary AML and CML cells could be induced into AML-DCs and CML-DCs, but their antigen presenting function are weaker.
出处 《郑州大学学报(医学版)》 CAS 北大核心 2008年第4期668-671,共4页 Journal of Zhengzhou University(Medical Sciences)
基金 江西省卫生厅科研基金资助项目20051104
关键词 白血病 髓系 树突状细胞 细胞表型 leukemia, myeloid dendritic cells cytophenotype
  • 相关文献

参考文献9

二级参考文献30

  • 1童向民,金洁,钱文斌,孟海涛,薛永权.慢性髓系白血病来源的树突状细胞生物学特性的研究[J].浙江大学学报(医学版),2005,34(4):348-352. 被引量:5
  • 2ABDEL-WAHAB Z,DEMATOS P,HESTER D,et al.Human dendritic cells,pulsed with either melanoma tumor cell lysates or the gp100 peptide(280 -288),induce pairs of T-cell cultures with similar phenotype and lyric activity[J].Cell Immunol,1998,186(1):63 -74. 被引量:1
  • 3MUKHERJI B,CHAKRABORTY N G,YAMASAKI S,et al.Induction of antigen-specific cytolytic T cells in situ in human melanoma by immunization with synthetic peptide-pulsed autologous antigen presenting cells [J].Proc Natl Acad Sci USA,1995,92 (17):8078 -8082. 被引量:1
  • 4EPPLER E,HORIG H,KAUFMAN H L,et al.Carcinoembryonic antigen (CEA) presentation and specific T cell-priming by human dendritic cells transfected with CEA-mRNA[J].Eur J Cancer,2002,38 (1):184-193. 被引量:1
  • 5PACZESNY S,UENO H,FAY J,et al.Dendritic cells as vectors for immunotherapy of cancer[J].Semin Cancer Biol,2003,13 (6):439- 447. 被引量:1
  • 6LISSONI P,VIGORE L,FERRANTI R,et al.Circulating dendritic cells in early and advanced cancer patients:diminished percent in the metastatic disease [J].J Biol Regul Homeost Agents,1999,13 (4):216 -219. 被引量:1
  • 7IINUMA T,HOMMA S,NODA T,et al.Prevention of gastrointestinal tumors based on adenomatous polyposis coli gene mutation by dendritic cell vaccine[J].J Clin Invest,2004,113(9):1307 - 1317. 被引量:1
  • 8Nestle FO, Alijagic S, Gilliet M, et al. Vaccination of melanoma patients with peptide or tumor lysate pulsed dendritic cells [J]. Nat Med, 1998, 4(3): 328-332. 被引量:1
  • 9Meidenbauer N, Andreesen R, Mackensen A. Dendritic cells for specific cancer immunotherapy [J]. Biol Chem, 2001,382(4):507-520. 被引量:1
  • 10Quah B, O'Neill HC. Review: the application of dendritic cell-derived exosomes in tumour immunotherapy [J]. Cancer Biother Radiopharm, 2000,15(2):185-194. 被引量:1

共引文献22

同被引文献15

  • 1童向民,金洁,钱文斌,孟海涛,薛永权.慢性髓系白血病来源的树突状细胞生物学特性的研究[J].浙江大学学报(医学版),2005,34(4):348-352. 被引量:5
  • 2顾龙君.儿童急性淋巴细胞白血病诊疗建议(第三次修订草案)[J].中华儿科杂志,2006,44(5):392-395. 被引量:472
  • 3Bassan R, Hoelzer D. Modem therapy of acute lympho- blastic leukemia [J]. J Clin Oncol, 2011, 29 ( 5 ) : 532- 543. 被引量:1
  • 4Robson N C, Hoves S, Maraskovsky E, et al. Presenta- tion of tumour antigens by dendritic cells and challenges faced[ J ]. Curr Opin Immunol, 2010, 22 ( 1 ) : 137-144. 被引量:1
  • 5Yao Y, Yang Z, Sun H, et al. Hydrothermal synthesis of Co304-graphene for heterogeneous activation of peroxym- onosulfate for decomposition of phenol [J]. Ind Eng Chem Res, 2012, 51 (46) :14958-14965. 被引量:1
  • 6Lee J J, Park M S, Park J S, et al. Induction of leuke- mic-cell-specific cytotoxic T lymphocytes by autologous monocyte-derived dendritic cells presenting leukemic cell antigens [J]. J Clin Apher, 2006, 21 ( 3 ) : 188-194. 被引量:1
  • 7Fay J W, Palucka A K, Paczesny S, et al. Long-term outcomes in patients with metastatic melanoma vaccinated with melanoma peptide-pulsed CD34 + progenitor-derived dendritic cells E J . Cancer Imrnunol Immun, 2006, 55 (10) :1209-1218. 被引量:1
  • 8Amigorena S, Savina A. Intracellular mechanisms of an- tigen cross presentation in dendritic cells [J]- Cult Opin Immunol, 2010, 22(1 ) : 109-117. 被引量:1
  • 9Shurin G V, Tourkova I L, Chatta G S, et al. Small Rho GTPase regulate antigen presentation in dendritic ceils[J]. J Immunol, 2005, 174(6) :3394-3400. 被引量:1
  • 10van den Hoorn T, Paul P, Jongsma M L, et al. Routes to manipulate MHC class II antigen presentation [ J ]. Curt Opin Immunol, 2011, 23 (1) .88-95. 被引量:1

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部